Nianfei Xian
Papers
1
Total Citations
66
H-Index
1
About
Dr. Nianfei Xian is pioneering the intersection of microrobotics and immunotherapy, with a primary focus on developing biohybrid systems to treat inflammatory bowel disease (IBD). Their landmark 2024 work introduced the "algae-MΦNP-robot," a biohybrid microrobot that combines living microalgae with macrophage-derived nanoparticles. This innovative platform actively regulates colonic cytokines and restores the epithelial barrier, addressing the root causes of IBD where conventional treatments often fall short. The paper has already garnered 66 citations, reflecting its immediate impact and promise for targeted, side-effect-free therapy. Dr. Xian’s research exemplifies a new paradigm in precision medicine, leveraging the motility of microorganisms and the bioactivity of immune cells to create intelligent, self-propelling therapeutic agents. By demonstrating that these microrobots can navigate the complex gastrointestinal environment and modulate local immune responses, their work opens avenues for treating a range of inflammatory and autoimmune conditions. Dr. Xian stands at the forefront of a rapidly evolving field, where engineering and biology converge to solve intractable medical challenges.
Research Focus
Key Achievements
Top Papers
- 1